Sol-Gel Technologies (SLGL) Operating Leases (2019 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Operating Leases came in at $377000.0 in Q1 2026, down 49.46% year-on-year from $746000.0 in Q1 2025, and down 23.99% on a QoQ basis from $496000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Operating Leases (2019 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 8 years of Operating Leases data on file, last reported at $377000.0 in Q1 2026.
- On a quarterly basis, Operating Leases fell 49.46% year-over-year to $377000.0 in Q1 2026; TTM through Mar 2026 was $377000.0, a 49.46% decrease from a year earlier, with the FY2025 full-year figure at $496000.0, down 43.51% from the prior year.
- Operating Leases for Q1 2026 stood at $377000.0, down from $496000.0 in the prior quarter.
- Over the last five years, Operating Leases for SLGL reached as high as $1.2 million in Q3 2023 and fell as low as $30000.0 in Q1 2023.
- Historically, Operating Leases has averaged $627764.7 across 5 years, with a median of $600000.0 in 2022.
- Across the five-year window, Operating Leases tumbled 95.0% in 2023 and surged 3676.67% in 2024, its largest moves.
- Year by year, Operating Leases stood at $54000.0 in 2022, then surged by 2133.33% to $1.2 million in 2023, then fell by 27.2% to $878000.0 in 2024, then slumped by 43.51% to $496000.0 in 2025, then retreated by 23.99% to $377000.0 in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $377000.0 in Q1 2026, $496000.0 in Q4 2025, and $592000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377,000.00 |
| Dec 31, 2025 | 496,000.00 |
| Sep 30, 2025 | 592,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 878,000.00 |
| Sep 30, 2024 | 922,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 369,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Dec 31, 2021 | 810,000.00 |
| Sep 30, 2021 | 803,000.00 |
| Jun 30, 2021 | 958,000.00 |